⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GNPX News
Genprex, Inc. Common Stock
Form 8-K
sec.gov
GNPX
AZN
GNE
Genprex Signs Sponsored Research Agreement to Study Biomarkers that May Predict Patient Response to Reqorsa® Gene Therapy
prnewswire.com
GNPX
Flagship Pioneering Launches Serif Biomedicines to Establish Modified DNA as a New Biotechnology
prnewswire.com
GNPX
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
prnewswire.com
GNPX
Form 8-K
sec.gov
GNPX
Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting
prnewswire.com
GNPX
Form 8-K
sec.gov
GNPX
Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer
prnewswire.com
GNPX
EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight
prnewswire.com
AVBP
SMMT
MRUS
MRK
GNPX
CGEM
ABBV
BMY
BDTX
LTRN
PFE
JNJ
LLY
Genprex Announces IP Australia's Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
prnewswire.com
GNPX